首页> 外国专利> Cell populations comprising CD31-positive, CD45-negative, CD200-positive mammalian cells, and use thereof

Cell populations comprising CD31-positive, CD45-negative, CD200-positive mammalian cells, and use thereof

机译:包含CD31阳性,CD45阴性,CD200阳性哺乳动物细胞的细胞群及其用途

摘要

Provided are: a cell population which is essentially formed from mammalian cells in which cell surface markers CD31 and CD200 are positive, and cell surface marker CD45 is negative; a cell population which is essentially formed from mammalian cells in which cell surface markers CD31, CD157, and CD200 are positive, and cell surface marker CD45 is negative; mammalian vascular endothelial stem cells in which cell surface marker CD31 is positive, cell surface marker CD157 and/or cell surface marker CD200 are/is positive, and cell surface marker CD45 is negative; and a revascularizing pharmaceutical having, as an active ingredient, the cell populations or the vascular endothelial stem cells.
机译:提供:基本上由哺乳动物细胞形成的细胞群,其中细胞表面标记CD31和CD200为阳性,而细胞表面标记CD45为阴性;基本由哺乳动物细胞形成的细胞群,其中细胞表面标记CD31,CD157和CD200为阳性,而细胞表面标记CD45为阴性。哺乳动物血管内皮干细胞,其中细胞表面标记CD31为阳性,细胞表面标记CD157和/或细胞表面标记CD200为阳性,并且细胞表面标记CD45为阴性。以及以细胞群或血管内皮干细胞为有效成分的血运重建药物。

著录项

  • 公开/公告号AU2018367552A1

    专利类型

  • 公开/公告日2020-06-25

    原文格式PDF

  • 申请/专利权人 OSAKA UNIVERSITY;

    申请/专利号AU20180367552

  • 申请日2018-11-15

  • 分类号C12N5/077;A61K35/44;A61P3/02;A61P3/06;A61P3/10;A61P7/04;A61P9;A61P9/10;A61P9/12;A61P19/10;C12Q1/02;

  • 国家 AU

  • 入库时间 2022-08-21 11:12:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号